Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $107.27 million. The enterprise value is $151.09 million.
Important Dates
The next estimated earnings date is Tuesday, March 10, 2026, before market open.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.65 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 16.65M |
| Shares Outstanding | 16.65M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 40.48% |
| Owned by Institutions (%) | 34.55% |
| Float | 9.91M |
Valuation Ratios
The trailing PE ratio is 62.86.
| PE Ratio | 62.86 |
| Forward PE | n/a |
| PS Ratio | 0.56 |
| Forward PS | 0.47 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | 11.90 |
| P/OCF Ratio | 8.49 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.17, with an EV/FCF ratio of 16.88.
| EV / Earnings | 87.95 |
| EV / Sales | 0.81 |
| EV / EBITDA | 12.17 |
| EV / EBIT | 21.46 |
| EV / FCF | 16.88 |
Financial Position
The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.39.
| Current Ratio | 2.99 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 3.92 |
| Debt / FCF | 6.01 |
| Interest Coverage | 1.83 |
Financial Efficiency
Return on equity (ROE) is 1.28% and return on invested capital (ROIC) is 2.91%.
| Return on Equity (ROE) | 1.28% |
| Return on Assets (ROA) | 2.23% |
| Return on Invested Capital (ROIC) | 2.91% |
| Return on Capital Employed (ROCE) | 3.73% |
| Weighted Average Cost of Capital (WACC) | 7.77% |
| Revenue Per Employee | $277,988 |
| Profits Per Employee | $2,560 |
| Employee Count | 671 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 2.93 |
Taxes
In the past 12 months, Ultralife has paid $568,000 in taxes.
| Income Tax | 568,000 |
| Effective Tax Rate | 24.66% |
Stock Price Statistics
The stock price has decreased by -9.76% in the last 52 weeks. The beta is 0.86, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -9.76% |
| 50-Day Moving Average | 6.01 |
| 200-Day Moving Average | 6.69 |
| Relative Strength Index (RSI) | 51.03 |
| Average Volume (20 Days) | 51,945 |
Short Selling Information
The latest short interest is 99,256, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 99,256 |
| Short Previous Month | 142,306 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, Ultralife had revenue of $186.53 million and earned $1.72 million in profits. Earnings per share was $0.10.
| Revenue | 186.53M |
| Gross Profit | 44.56M |
| Operating Income | 7.04M |
| Pretax Income | 2.30M |
| Net Income | 1.72M |
| EBITDA | 12.41M |
| EBIT | 7.04M |
| Earnings Per Share (EPS) | $0.10 |
Full Income StatementBalance Sheet
The company has $9.26 million in cash and $53.80 million in debt, with a net cash position of -$44.54 million or -$2.68 per share.
| Cash & Cash Equivalents | 9.26M |
| Total Debt | 53.80M |
| Net Cash | -44.54M |
| Net Cash Per Share | -$2.68 |
| Equity (Book Value) | 137.43M |
| Book Value Per Share | 8.24 |
| Working Capital | 66.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $12.55 million and capital expenditures -$3.60 million, giving a free cash flow of $8.95 million.
| Operating Cash Flow | 12.55M |
| Capital Expenditures | -3.60M |
| Free Cash Flow | 8.95M |
| FCF Per Share | $0.54 |
Full Cash Flow StatementMargins
Gross margin is 23.89%, with operating and profit margins of 3.77% and 0.92%.
| Gross Margin | 23.89% |
| Operating Margin | 3.77% |
| Pretax Margin | 1.23% |
| Profit Margin | 0.92% |
| EBITDA Margin | 6.65% |
| EBIT Margin | 3.77% |
| FCF Margin | 4.80% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.50% |
| Shareholder Yield | -0.50% |
| Earnings Yield | 1.61% |
| FCF Yield | 8.40% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 1.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.94 |
| Piotroski F-Score | 4 |
